» Articles » PMID: 2153437

Natural Killer Cell Activity in Patients with Hepatocellular Carcinoma Relative to Early Development and Tumor Invasion

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1990 Feb 15
PMID 2153437
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the significance of natural killer (NK) cell activity in the clinical assessment of patients with hepatocellular carcinoma (HCC), 32 patients combined with liver cirrhosis (LC) and HCC, and 29 LC patients were studied. The NK cell activity was markedly decreased in HCC patients and the LC group as compared with the control group, but there was no statistical difference between the NK cell activity of the HCC group and the LC group. The depression of NK cell activity in HCC patients was inversely correlated with the patient's age, and the HCC patients with venous invasion or with both lobes involved had lower NK cell activity. These results suggest that the decreased NK cell activity in HCC patients might be related to the coexistent liver disease, and marked decrease in NK cell activity might be one of the causes for the early development and invasion of HCC.

Citing Articles

A Phase I Study of Locoregional High-Dose Autologous Natural Killer Cell Therapy With Hepatic Arterial Infusion Chemotherapy in Patients With Locally Advanced Hepatocellular Carcinoma.

Bae W, Lee B, Kim H, Lee J, Chung I, Bum Cho S Front Immunol. 2022; 13:879452.

PMID: 35720374 PMC: 9202498. DOI: 10.3389/fimmu.2022.879452.


A brief review concerning Chimeric Antigen Receptors T cell therapy.

Li L, Yuan H, Yang Y, Wang L, Zou R J Cancer. 2020; 11(18):5424-5431.

PMID: 32742489 PMC: 7391193. DOI: 10.7150/jca.46308.


Immunotherapy for hepatocellular carcinoma: Current and future.

Johnston M, Khakoo S World J Gastroenterol. 2019; 25(24):2977-2989.

PMID: 31293335 PMC: 6603808. DOI: 10.3748/wjg.v25.i24.2977.


Complete response of hepatocellular carcinoma with right atrium and pulmonary metastases treated by combined treatments (a possible treatment effect of natural killer cell): A case report and literature review.

Kim D, Cho E, Bum Cho S, Choi S, Kim S, Yu J Medicine (Baltimore). 2018; 97(42):e12866.

PMID: 30334999 PMC: 6211840. DOI: 10.1097/MD.0000000000012866.


Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review.

Hosseinzadeh F, Verdi J, Ai J, Hajighasemlou S, Seyhoun I, Parvizpour F Cancer Cell Int. 2018; 18:133.

PMID: 30214375 PMC: 6131874. DOI: 10.1186/s12935-018-0624-x.